This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Biochromix Newco Ab, Celluminova Ab. Active years: 2014-2015.
Location History:
- Linköping, SE (2014)
- Linkoping, SE (2015)
Company Filing History:
Years Active: 2014-2015
Title: Innovations by Andreas Åslund
Introduction
Andreas Åslund is a notable inventor based in Linkoping, Sweden. He has made significant contributions to the field of molecular probes and compounds, holding a total of 2 patents. His work focuses on the detection of neural stem cells and neural cancer stem cells, showcasing his commitment to advancing scientific knowledge and medical applications.
Latest Patents
Andreas Åslund's latest patents include innovative developments in oligothiophene derivatives. The first patent, titled "Oligothiophene derivate as molecular probes," relates to oligothiophene derivatives that bind specifically to neural stem cells and neural cancer stem cells. This invention provides methods for detecting these cells in biological samples, along with associated uses and kits. The second patent, "Substituted thiophene pentamers," presents a compound formula where various components can be selected to create pharmaceutically acceptable salts, further expanding the potential applications of his work.
Career Highlights
Throughout his career, Andreas has worked with several companies, including Celluminova AB and Biochromix Newco AB. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in biotechnology and molecular research.
Collaborations
Andreas has collaborated with notable colleagues such as Peter Konradsson and Ola Hermansson. These partnerships have likely enriched his research and development efforts, fostering a collaborative environment for innovation.
Conclusion
Andreas Åslund's contributions to the field of molecular probes and compounds highlight his role as a significant inventor. His patents reflect a dedication to advancing medical science and improving detection methods for critical biological components.